35988518|t|Novel melatonin-trientine conjugate as potential therapeutic agents for Alzheimer's disease.
35988518|a|Researchers continue to explore drug targets to treat the characteristic pathologies of Alzheimer's disease (AD). Some drugs relieve the pathological processes of AD to some extent, but the failed clinical trials indicate that multifunctional agents seem more likely to achieve the therapy goals for this neurodegenerative disease. Herein, a novel compound named melatonin-trientine (TM) has been covalently synthesized with the natural antioxidant compounds melatonin and the metal ion chelator trientine. After toxicological and pharmacokinetic verification, we elucidated the effects of intraperitoneal administration of TM on AD-like pathology in 6-month-old mice that express both the beta-amyloid (Abeta) precursor protein and presenilin-1 (APP/PS1). We found that TM significantly decreased Abeta deposition and neuronal degeneration in the brains of the APP/PS1 double transgenic mice. This result may be due to the upregulation of iron regulatory protein-2 (IRP2), insulin degrading enzyme (IDE), and low density lipoprotein receptor related protein 1 (LRP1), which leads to decreases in APP and Abeta levels. Additionally, TM may promote APP non-amyloidogenic processing by activating the melatonin receptor-2 (MT2)-dependent signaling pathways, but not MT1. In addition, TM plays an important role in blocking gamma-secretase, tau hyperphosphorylation, neuroinflammation, oxidative stress, and metal ion dyshomeostasis. Our results suggest that TM may effectively maximize the therapeutic efficacy of targeting multiple mechanisms associated with AD pathology.
35988518	6	25	melatonin-trientine	Chemical	-
35988518	72	91	Alzheimer's disease	Disease	MESH:D000544
35988518	181	200	Alzheimer's disease	Disease	MESH:D000544
35988518	202	204	AD	Disease	MESH:D000544
35988518	256	258	AD	Disease	MESH:D000544
35988518	398	423	neurodegenerative disease	Disease	MESH:D019636
35988518	456	475	melatonin-trientine	Chemical	-
35988518	477	479	TM	Chemical	MESH:D013932
35988518	552	561	melatonin	Chemical	MESH:D008550
35988518	570	579	metal ion	Chemical	-
35988518	589	598	trientine	Chemical	MESH:D014266
35988518	717	719	TM	Chemical	MESH:D013932
35988518	723	725	AD	Disease	MESH:D000544
35988518	756	760	mice	Species	10090
35988518	797	802	Abeta	Gene	11820
35988518	826	838	presenilin-1	Gene	19164
35988518	844	847	PS1	Gene	19164
35988518	864	866	TM	Chemical	MESH:D013932
35988518	891	896	Abeta	Gene	11820
35988518	912	933	neuronal degeneration	Disease	MESH:D009410
35988518	959	962	PS1	Gene	19164
35988518	981	985	mice	Species	10090
35988518	1033	1058	iron regulatory protein-2	Gene	64602
35988518	1060	1064	IRP2	Gene	64602
35988518	1067	1091	insulin degrading enzyme	Gene	15925
35988518	1093	1096	IDE	Gene	15925
35988518	1103	1153	low density lipoprotein receptor related protein 1	Gene	16971
35988518	1155	1159	LRP1	Gene	16971
35988518	1198	1203	Abeta	Gene	11820
35988518	1226	1228	TM	Chemical	MESH:D013932
35988518	1357	1360	MT1	Gene	17748
35988518	1375	1377	TM	Chemical	MESH:D013932
35988518	1457	1474	neuroinflammation	Disease	MESH:D000090862
35988518	1498	1507	metal ion	Chemical	-
35988518	1549	1551	TM	Chemical	MESH:D013932
35988518	1651	1653	AD	Disease	MESH:D000544
35988518	Negative_Correlation	MESH:D013932	MESH:D009410
35988518	Negative_Correlation	MESH:D013932	MESH:D000544
35988518	Negative_Correlation	11820	64602
35988518	Positive_Correlation	MESH:D013932	16971
35988518	Positive_Correlation	MESH:D013932	15925
35988518	Negative_Correlation	11820	15925
35988518	Association	11820	16971
35988518	Negative_Correlation	MESH:D013932	11820
35988518	Negative_Correlation	MESH:D013932	MESH:D000090862
35988518	Positive_Correlation	MESH:D013932	64602

